首页|期刊导航|中华医学杂志(英文版)|Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China
中华医学杂志(英文版)2016,Vol.129Issue(3):304-308,5.DOI:10.4103/0366-6999.174509
Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China
Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China
摘要
关键词
Antiretroviral Therapy/Co-infection/Hepatitis B Virus/Human Immunodeficiency Virus/Tenofovir Disoproxil FumarateKey words
Antiretroviral Therapy/Co-infection/Hepatitis B Virus/Human Immunodeficiency Virus/Tenofovir Disoproxil Fumarate引用本文复制引用
Ya-Song Wu,Wei-Wei Zhang,Xue-Mei Ling,Lian Yang,Shao-Biao Huang,Xi-Cheng Wang,Hao Wu..Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China[J].中华医学杂志(英文版),2016,129(3):304-308,5.基金项目
This study was supported by Gilead Sciences (co-us1040405), and in part by the United States CDC Global AIDS Program (GAP) for HBV DNA testing. (co-us1040405)